Takeda Pharmaceutical
TAK
#498
Rank
โ‚ฌ40.48 B
Marketcap
12,17ย โ‚ฌ
Share price
-0.70%
Change (1 day)
-4.30%
Change (1 year)

Earnings for Takeda Pharmaceutical (TAK)

Earnings in 2025 (TTM): โ‚ฌ1.71 Billion

According to Takeda Pharmaceutical's latest financial reports the company's current earnings are โ‚ฌ29.52 Billion. In 2024 the company made an earning of โ‚ฌ1.91 Billion a decrease over its 2023 earnings that were of โ‚ฌ1.96 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Takeda Pharmaceutical from 2009 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) โ‚ฌ1.71 B-10.32%
2024 โ‚ฌ1.91 B-2.41%
2023 โ‚ฌ1.96 B-28.14%
2022 โ‚ฌ2.72 B-40.9%
2021 โ‚ฌ4.61 B78.24%
2020 โ‚ฌ2.59 B246.1%
2019 โ‚ฌ0.74 B-48.79%
2018 โ‚ฌ1.46 B-23.64%
2017 โ‚ฌ1.91 B21.7%
2016 โ‚ฌ1.57 B-253.01%
2015 -โ‚ฌ1.03 Billion-159.65%
2014 โ‚ฌ1.72 B13%
2013 โ‚ฌ1.52 B2.46%
2012 โ‚ฌ1.48 B-57.05%
2011 โ‚ฌ3.46 B-10.49%
2010 โ‚ฌ3.87 B-3.99%
2009 โ‚ฌ4.03 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ27.79 B 1,481.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚ฌ7.80 B 344.15%๐Ÿ‡ซ๐Ÿ‡ท France
Pfizer
PFE
โ‚ฌ10.16 B 478.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚ฌ14.08 B 701.36%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Seagen
SGEN
-โ‚ฌ0.68 Billion-138.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Dr. Reddy's Laboratories
RDY
โ‚ฌ0.78 B-55.15%๐Ÿ‡ฎ๐Ÿ‡ณ India
Amgen
AMGN
โ‚ฌ7.07 B 302.36%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
โ‚ฌ7.99 B 355.02%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
โ‚ฌ19.80 B 1,026.95%๐Ÿ‡บ๐Ÿ‡ธ USA